Clinical Trials Browser

OTHER × Carcinoma, Ovarian Epithelial × veliparib × Clear all

NCT01472783 2016-11-16

Veli-BRCA

Phase 1/2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

NCT01690598 2015-06-10

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Phase 1/2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms